About this page
ACRS — Aclaris Therapeutics
Why Aclaris Therapeutics (ACRS) moved: the last session's move split into the market, its industry, its themes and the part unique to the company, with our latest explained moves and their sources, beside the live chart.
On Friday, November 20, 2026, Aclaris Therapeutics (ACRS) fell 1.71% at the close. Where it came from: Market (SPY) -5.10%, Biotech & Genomics +1.79%, Pharmaceuticals +0.09%, Factors (6) +0.93%, Unique to ACRS +0.58%. The market drove most of ACRS's decline.
Fell with the market: chipmakers led it lower on Anthropic headlines (Yahoo). The stories that moved the market.
Aclaris Therapeutics (ACRS) last reported earnings on Thursday, November 5, 2026, before the open (SEC 8-K); that session, ACRS fell 1.90% at the close. Its next report is estimated for about Thursday, February 4, 2027 (between February 3 and February 5), before the open, from its own rhythm across 10 reports; not yet announced. The earnings calendar.
TickerTiles has explained 2 of ACRS's moves in the last six months — Monday, November 16, 2026 (fell 8.0%) and Tuesday, October 27, 2026 (fell 6.9%). The catalyst behind each, with its sources, is on this page.
Each explained move has its own page: Monday, November 16, 2026 · Tuesday, October 27, 2026.
Only on this page: ACRS's split updating every minute while the market is open, which of the 6 factors moved it and by how much, and the catalyst behind each of its 2 explained moves, with sources.
Explore daily moves on this page shows where ACRS's moves came from, session by session — the market, its industry, its themes, its factors and its own part. The month and three-month views are free; six months, the year to date and the full year, with every day's breakdown and its full explanation, are part of TickerTiles Plus.
All stocks: Why stocks moved. The whole market: Market Overview.